The mechanism by which GSAP (γ-secretase activating protein) regulates γ-secretase activity has not yet been elucidated. Here, we show that knockout of GSAP in cultured cells directly reduces γ-secretase activity for Aβ production, but not for Notch1 cleavage, suggesting that GSAP may induce a conformational change contributing to the specificity of γ-secretase. Furthermore, using an active site directed photoprobe with double cross-linking moieties, we demonstrate that GSAP modifies the orientation and/or distance of PS1-NTF and PS1-CTF, a region containing the active site of γ-secretase. This work offers insight into how GSAP regulates γ-secretase specificity.
Introduction
γ-secretase is a large intramembrane protein complex comprised of four essential components, Presenilin 1 (PS1), Nicastrin (NCT), Anterior pharynx-defective 1 (Aph1) and Presenilin enhancer 2 (Pen2) 1, 2 . PS1 is the catalytic core of the complex [3] [4] [5] , and requires an activation step by endoproteolysis 6 that is dependent on Pen-2. 5, 7, 8 . In addition to these mandatory subunits, γ-secretase is also regulated by nonessential proteins, such as CD147, TPM21, the γ-secretase activating protein (GSAP) and Hif-1α [9] [10] [11] [12] . GSAP is a ~98 kDa holoprotein, which undergoes extensive processing resulting in a ~16 kDa C-terminal fragment 12 . This fragment was found to form a ternary complex with γsecretase and βCTF and to regulate the cleavage at the γ-sites, but not ϵsites, controlling the generation of Aβ and AICD, respectively.
Decreasing GSAP expression in cells significantly reduced Aβ levels 12, 13 without affecting the cleavage of other substrates, such as Notch 12 .
However, the role of GSAP in the regulation of γ-secretase has been challenged 13 due to lack of direct mechanistic evidence. Nevertheless, GSAP RNAi mice crossed with double transgenic APPsweXPS1ΔE9 AD model mice have reduced Aβ burden 12 , indicating that GSAP is a novel therapeutic target for the treatment of AD. Furthermore, genetic studies have shown that GSAP is linked with aging, AD and Down syndrome [14] [15] [16] . Therefore, investigating the function of GSAP in Aβ production and γ-secretase activity and specificity is critical for developing an in-depth understanding of γ-secretase modulation and effective AD therapeutics.
However, such studies have been hindered due to lack of suitable technologies.
Results and Discussions
Previous studies examined the function of GSAP using siRNA knockdown methods 12, 13 . To further investigate the role of GSAP in γsecretase regulation, we knocked out (KO) GSAP with CRISPR/Cas9 technology in HEK293 cells that stably express APP (HEK-APP). KO of GSAP was confirmed by genomic sequencing (data not shown). mRNA levels of GSAP in GSAP-KO cells were not detectable ( Fig. 1A) , whereas the expression of APP mRNA was not changed (data not shown). Secretion of Aβ40 and Aβ42 in the GSAP-KO cells was only 75% and 73% of HEK-APP WT cells, respectively ( Fig. 1B and C).
To directly measure the effect of GSAP on γ-secretase activity, we performed exo-cell assays 17 using recombinant APP or Notch substrate 18 , which allows for the immediate and real-time analysis of γsecretase activity for both substrates. HEK-APP WT and GSAP KO cells were seeded in a 96-well plate overnight. The recombinant substrates were then added to the cells in the presence of CHAPSO and incubated for 2.5 hours to measure γ-secretase cleavage. The cleaved products were detected with an AlphaLISA assay 18 . γ-Secretase activity was calculated by normalizing to protein concentration. HEK-APP GSAP KO cells have only 71 % γ-secretase activity for Aβ40 production compared to WT (Fig.   1C ), but the same level of Notch1 cleavage ( Fig. 1D ), indicating that GSAP solely impacts the processing of APP without affecting Notch processing. Next, we tested whether the reduced γ-secretase activity and Aβ secretion were a result of changes in expression levels of the γsecretase subunits. The protein levels of APP, PS1-NTF, Nct, Aph1a and Pen2 remained unchanged in HEK-APP KO compared to WT ( Fig. 1E ), indicating that GSAP-KO directly affects γ-secretase activity without altering overall steady-state levels of γ-secretase subunits. The same conclusion was reached when we assayed cell membranes prepared from both WT and KO cells (data not shown). In addition, we generated GSAP-KO SH-5YSY cells and found that GSAP-KO reduces γ-secretase activity for Aβ40, but not for Notch cleavage (Fig. S1 ).
To determine whether the reduction of -secretase activity in the GSAP KO cells directly results from elimination of GSAP, we performed rescue studies by overexpressing GSAP in the KO cells.
Empty vector (EV) or the full-length human GSAP with a C-terminal HA tag (hGSAP) construct was transfected into the HEK-APP WT or GSAP KO cells and secreted Aβ species were measured 48 hours post transfection. We found that overexpression of hGSAP in HEK-APP KO cells can fully, or partially restore secreted Aβ40 and Aβ42 ( Fig. 2A and   B ). However, overexpression of hGSAP in WT HEK-APP cells had no effect on Aβ secretion, indicating that the endogenous level of GSAP is sufficient for γ-secretase activation for the processing of APP. Next, we measured γ-secretase activity using cell membranes prepared 48 hours post transfection. In agreement with the Aβ production data, expression of hGSAP in KO cells rescued γ-secretase activity for APP, but the γsecretase activity remained unchanged in the WT membrane ( Fig 2C) .
Remarkably, γ-secretase activity for cleavage of recombinant Notch substrate was not changed with GSAP overexpression in any of the cell lines ( Fig. 2D ). Expression of hGSAP, migrating as expected at ∼98 kDa protein, was confirmed by Western blot using anti-HA antibodies ( Fig.   2E ). Moreover, the overexpression of GSAP did not alter the expression of APP or PS1 ( Fig. 2E ). Similar results were obtained rescuing the γsecretase activity and Aβ secretion with SH-5YSY GSAP-KO cells (Fig.   S2 ). The expression of GSAP on the GSAP-KO background can rescue γ-secretase activity for the processing of APP, demonstrating that the GSAP-KO effect on γ-secretase activity comes from the abolition of GSAP.
Collectively, these results indicate 1) that GSAP knockout reduces γ-secretase activity towards APP but not Notch, 2) that the level of endogenous GSAP in the WT cells is saturated to modulate γ-secretase activity, and 3) that exogenous overexpression of GSAP cannot further enhance γ-secretase cleavage in WT cells.
To better understand the effect of GSAP on γ-secretase, we measured the kinetics of γ-secretase in membrane fractions prepared Fig. 3A and B) . Second, transfection of hGSAP in the KO cells increased Vmax (αLISA arbitrary unit) without modifying the Km value (µM) ( Fig.   3B and C) but had no effect on HEK GSAP WT γ-secretase. Finally, γsecretase from all four cell lines had similar Km and Vmax values for Notch substrate regardless of WT or KO and hGSAP transfection ( Fig   3D-F) . These results indicate that GSAP does not change the binding of γ-secretase to APP substrate, but rather alters the Vmax. Moreover, GSAP specifically modulates γ-secretase for Aβ production, but not Notch1 cleavage.
Kinetic analysis suggests that GSAP might alter the active site of γ-secretase leading to different catalytic efficiency for APP substrates.
To detect the changes in the active site in the presence and absence of GSAP, we used active site-directed γ-secretase inhibitors that directly interact with PS1-NTF and -CTF 4, 18 . L631 contains two benzoylphenylalanine (BPA) groups at its P2 and P3' positions allowing for the photolabeling of γ-secretase ( Fig. 4A) 19 . L631 has been demonstrated to label PS1-NTF, PS1-CTF and cross-linked PS1-NTF and PS1-CTF together 19 . The photolabeling efficiency depends on direct contact between the residues and the corresponding subpockets (S2 and S3') in the active site ( Fig. 4A ). Any conformational changes induced by GSAP, which alter the distance or orientation between a subpocket and the photoprobe, may lead to different cross-linking efficiencies 18 . Four cell type membranes (WT-EV, WT-hGSAP, KO-EV and KO-hGSAP) were photolabeled with L631. Labeled species were isolated by streptavidin beads and analyzed by PS1-NTF and PS1-CTF antibodies.
L631 photolabels both PS1-NTF ( Fig 4B upper panels, ~34 kD band) and PS1 CTF ( Fig 4B lower panels, ~20 kD band) in membranes from all four cell lines. One striking difference is that L631 doesn't cross-link PS1-NTF and PS1-CTF together (a ~55 kDa band) in GSAP deficient cells (KO-EV) ( Fig. 4B ) and the labeling of the 55 kDa band can be restored by the re-expression of GSAP (KO-hGSAP). In the presence of GSAP, we propose that PS1-NTF and PS1-CTF align in a specific conformation in which L631 can cross-link the two fragments, resulting in higher γsecretase activity for Aβ production. However, when GSAP is absent, the conformation of the active site is transformed into a different form, which does not allow for L631 to cross-link the two fragments ( Fig. 4C) and Although the effect of GSAP on the production of Aβ has been established, its role in the activation and specificity of γ-secretase has been controversial 20 . In the present study, we show that knockout of GSAP cell lines using CRISPR/CAS9 reduces Aβ production and γsecretase activity. We found that GSAP knockout decreases γ-secretase activity towards APP, but not Notch substrate in vitro. Moreover, the reduction of Aβ and γ-secretase activity was rescued by overexpressing human full-length GSAP in the knockout cells. Furthermore, our photolabeling studies indicate that γ-secretase has at least two conformations modulated through GSAP. Switching between these two forms can affect γ-secretase activity for Aβ production, but not Notch1 cleavage. When GSAP is present in the cells, like in the WT or KO transfected with GSAP ( Fig. 5A ), PS1 adopts a native conformation allowing for the normal processing of APP and Notch. In this native conformation, PS1-NTF and -CTF are in a specific orientation allowing for the L631 photoprobe to cross-link the two fragments. However, KO of GSAP results in a different PS1 conformation, associated with a reduction of γ-secretase activity for APP, leading to reduction in Aβ secretion (Fig. 5B) . Our studies show that GSAP directly affects the conformation of the active site, providing proof that GSAP directly regulates γ-secretase activity and specificity. Our findings provide a route to the investigation of γ-secretase modulation and ultimately to the development of therapeutic agents for AD. mM MgCl2) and 0.25% CHAPSO detergent at 37°C for 3 hours. -Secretase products were detected by AlphaLISA methods using G2-10 or SM320 antibodies for Aβ40 or NICD, respectively 18 . Activity readout was expressed as arbitrary AlphaLISA units. Specific activity was normalized to protein concentration. Cell membrane preparation and gsecretase assays were described previously 18, 21, 22 Activity-based photoaffinity labeling. Active site-based photoaffinity labeling was performed with cell lines in 12-well tissue culture dish with 10 nM of L631 in Phosphate buffer saline (PBS) pH 7.4, 0.25%
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CHAPSO.
Photolabeling experiments were carried out as described previously 4 19 . Reaction mixtures were solubilized with RIPA buffer for 1 hour at room temperature and streptavidin beads were added to capture labeled PS1 at 4°C overnight. Beads were washed and eluted by boiling in 2X Laemmli sample buffer. Ensuing samples were resolved on SDS-PAGE followed by western blotting with PS1-NTF or PS1-CTF antibody. 
End Matter
Author Contributions and Notes
